Literature DB >> 9781527

Hypothalamic hamartomas and gelastic epilepsy: a spectroscopic study.

E Tasch1, F Cendes, L M Li, F Dubeau, J Montes, B Rosenblatt, F Andermann, D Arnold.   

Abstract

BACKGROUND: Patients with hypothalamic hamartomas present with epileptic attacks of laughter and later experience multiple seizure types and cognitive decline, suggestive of secondary generalized epilepsy. It has been suggested in the past that gelastic seizures originate in the temporal lobes rather than in the hamartoma, but temporal resections have been ineffective. Recent electrophysiologic evidence suggests that the epileptogenic discharges may originate in the hamartoma itself.
METHODS: We used proton magnetic resonance spectroscopic imaging to quantify the amount of neuronal damage in the temporal lobes and hamartomas of patients with hypothalamic hamartomas and gelastic seizures. Five patients were studied and the relative intensity of N-acetylaspartate to creatine (NAA/Cr) was determined for both temporal lobes as well as for the hamartoma. These values were compared with signals from the temporal lobes and hypothalami of normal control subjects.
RESULTS: NAA/Cr was not significantly different from normal control subjects for either temporal lobe, nor was there a significant asymmetry between the two temporal lobes for any of the patients. NAA resonance signals were present in the hamartomas, and the ratio of NAA to Cr was decreased in the hamartomas compared with the hypothalami of normal control subjects (t = 4.5, p = 0.005).
CONCLUSIONS: We found no detectable neuronal damage in the temporal lobes of patients with hypothalamic hamartomas and gelastic epilepsy. This is further evidence that gelastic seizures do not originate in the temporal lobes of these patients.

Entities:  

Mesh:

Year:  1998        PMID: 9781527     DOI: 10.1212/wnl.51.4.1046

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  5 in total

1.  MR imaging and spectroscopy of a tuber cinereum hamartoma in a patient with growth hormone deficiency and hypogonadotropic hypogonadism.

Authors:  David D Martin; Uwe Seeger; Michael B Ranke; Wolfgang Grodd
Journal:  AJNR Am J Neuroradiol       Date:  2003 Jun-Jul       Impact factor: 3.825

2.  Hypothalamic hamartomas: Correlation of MR imaging and spectroscopic findings with tumor glial content.

Authors:  D R Amstutz; S W Coons; J F Kerrigan; H L Rekate; J E Heiserman
Journal:  AJNR Am J Neuroradiol       Date:  2006-04       Impact factor: 3.825

3.  MR imaging and spectroscopic study of epileptogenic hypothalamic hamartomas: analysis of 72 cases.

Authors:  Jeremy L Freeman; Lee T Coleman; R Mark Wellard; Michael J Kean; Jeffrey V Rosenfeld; Graeme D Jackson; Samuel F Berkovic; A Simon Harvey
Journal:  AJNR Am J Neuroradiol       Date:  2004-03       Impact factor: 3.825

Review 4.  [Supratentorial tumors].

Authors:  I Grunwald; K Dillmann; C Roth; M Backens; W Reith
Journal:  Radiologe       Date:  2007-06       Impact factor: 0.635

Review 5.  Pathological laughter as prodromal manifestation of transient ischemic attacks--case report and brief review.

Authors:  Adriana O Dulamea; Costel Matei; Ioana Mindruta; Virgil Ionescu
Journal:  BMC Neurol       Date:  2015-10-12       Impact factor: 2.474

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.